디지털 바이오마커 시장 규모는 향후 몇 년동안 비약적인 성장을 보일 것으로 예상되며, 2028년까지 연평균 26.2%의 성장률로 99억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 의료 서비스 제공업체의 디지털 바이오마커 채택 증가, 만성질환 유병률 증가, 소비자 인식 증가, 피트니스 및 라이프스타일 모니터링에 대한 관심 증가에 기인할 것으로 보입니다. 주요 동향으로는 웨어러블 기술 발전, 인공지능과의 통합, 협업 및 제휴, 신흥 시장 진출, 전자의무기록과의 통합 등이 예상됩니다.
만성질환의 유병률 증가는 향후 몇 년동안 디지털 바이오마커 시장의 성장을 견인할 것으로 예상됩니다. 만성질환은 천천히 진행되어 평생 지속되는 장기적인 건강 상태입니다. 이러한 질병의 위험은 골관절염, 알츠하이머병, 심장병과 같은 노화 관련 질환, 가공식품의 과다 섭취, 신체 활동 감소와 같은 요인에 의해 증가합니다. 디지털 바이오마커는 건강 지표를 모니터링하고 질병의 진행을 실시간으로 추적하는 데 매우 중요하며, 보다 개인화되고 시기적절한 개입을 가능하게 합니다. 예를 들어, 2023년 5월 미국 질병예방통제센터(CDC)가 발표한 보고서에 따르면 2022년 심장병과 암으로 인한 사망자 수는 69만 5,547명으로 2021년 60만 5,213명에서 증가했다고 합니다. 이러한 만성 질환 증가는 디지털 바이오마커에 대한 수요를 증가시킬 것으로 예상됩니다.
디지털 바이오마커 시장의 주요 기업들은 전략적 파트너십을 추구하고 도달 범위를 넓히고 서비스를 강화하기 위해 노력하고 있습니다. 전략적 파트너십에는 자원, 전문 지식 및 노력을 결합하여 공동의 목표를 달성하기 위해 조직 간의 협력이 포함됩니다. 예를 들어, 미국의 임상 검사 자동화 업체인 ProofPilot은 2023년 9월 미국 제약회사 Eli Lilly and Company와 전략적 파트너십을 체결했습니다. 이 파트너십을 통해 릴리의 혁신적인 Magnol.AI 센서 클라우드 플랫폼이 ProofPilot의 기술 제품군에 통합되며, Magnol.AI는 고주파 센서 데이터를 고급 보안과 용이성으로 관리할 수 있도록 설계되었습니다. 이번 제휴는 실시간 데이터 과학 기능과 센서 데이터에서 더 깊은 통찰력을 제공함으로써 디지털 건강 연구를 개선하고 임상의와 환자가 보고하는 결과를 지원하여 디지털 건강 및 바이오마커 연구를 촉진하는 것을 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 거시경제 시나리오
- 고인플레이션이 시장에 미치는 영향
- 우크라이나·러시아 전쟁이 시장에 미치는 영향
- 시장에 대한 COVID-19의 영향
제5장 세계 시장 규모와 성장
- 세계의 디지털 바이오마커 시장 : 성장 촉진요인과 억제요인
- 세계의 디지털 바이오마커 시장 실적 : 규모와 성장, 2018-2023년
- 세계의 디지털 바이오마커 시장 예측 : 규모와 성장, 2023-2028년, 2033년
제6장 시장 세분화
- 세계의 디지털 바이오마커 시장 : 유형별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 웨어러블
- 모바일 기반 애플리케이션
- 센서
- 기타
- 세계의 디지털 바이오마커 시장 : 임상 실천별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 진단 디지털 바이오마커
- 모니터링 디지털 바이오마커
- 예측 및 예지 디지털 바이오마커
- 기타 임상 실천
- 세계의 디지털 바이오마커 시장 : 용도별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 종양학
- 대사성 질환
- 신경 질환
- 심장병
- 기타
- 세계의 디지털 바이오마커 시장 : 최종사용자별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 의료 기업
- 의료 제공업체
- 지불자
- 기타
제7장 지역별/국가별 분석
- 세계의 디지털 바이오마커 시장 : 지역별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 세계의 디지털 바이오마커 시장 : 국가별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 디지털 바이오마커 시장 : 경쟁 구도
- 디지털 바이오마커 시장 : 기업 개요
- Pfizer Inc
- Bayer AG
- F Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Koninklijke Philips NV(Philips)
제31장 기타 주요 기업 및 혁신 기업
- GE Healthcare
- Biogen Inc
- Garmin Ltd.
- Clario
- Verily Life Sciences LLC
- Altoida Inc.
- BioSerenity
- Oura Health Oy.
- Evidation Health Inc
- AliveCor Inc
- Empatica Inc
- ActiGraph LLC
- VivoSense Inc
- BioSensics LLC
- Koneksa Health Inc
제32장 경쟁 벤치마킹
제33장 경쟁 대시보드
제34장 주요 인수합병(M&A)
제35장 향후 전망과 잠재적인 분석
제36장 부록
LSH
Digital biomarkers are objective, quantifiable physiological and behavioral data collected using digital devices such as wearables, sensors, and mobile health applications. These biomarkers help monitor and predict health outcomes, enabling more accurate and personalized medical interventions. They facilitate continuous, real-time health monitoring, leading to improved disease management and personalized care.
The main types of digital biomarkers include wearables, mobile-based applications, sensors, and others. Wearable digital biomarkers are devices such as smartwatches or fitness trackers that monitor physiological signals such as heart rate, activity levels, and sleep patterns. Clinical practices for digital biomarkers are categorized into diagnostic, monitoring, predictive, and prognostic types, with applications across oncology, metabolic diseases, neurological disorders, cardiac conditions, and more. End users of digital biomarkers include healthcare companies, healthcare providers, payers, and other stakeholders.
The digital biomarkers market research report is one of a series of new reports from the business research company that provides digital biomarkers market statistics, including digital biomarkers industry global market size, regional shares, competitors with an digital biomarkers market share, detailed digital biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the digital biomarkers industry. This digital biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The digital biomarkers market size has grown exponentially in recent years. It will grow from $3.11 billion in 2023 to $3.92 billion in 2024 at a compound annual growth rate (CAGR) of 26%. The growth during the historic period can be attributed to the expansion of mobile health applications, early adoption in clinical trials, the increasing prevalence of chronic diseases, growing consumer interest in fitness and wellness, and the rise of healthcare digitization.
The digital biomarkers market size is expected to see exponential growth in the next few years. It will grow to $9.94 billion in 2028 at a compound annual growth rate (CAGR) of 26.2%. The growth during the forecast period can be attributed to the increasing adoption of digital biomarkers by healthcare providers, the rising prevalence of chronic diseases, greater consumer awareness, and growing interest in fitness and lifestyle monitoring. Major trends expected include advancements in wearable technology, integration with artificial intelligence, collaborations and partnerships, expansion into emerging markets, and integration with electronic health records.
The increasing prevalence of chronic diseases is expected to drive the growth of the digital biomarkers market in the coming years. Chronic diseases are long-lasting health conditions that progress slowly and often persist for life. The risk of these diseases is heightened by age-related conditions such as osteoarthritis, Alzheimer's disease, and heart disease, as well as factors such as high consumption of processed foods and decreased physical activity. Digital biomarkers are crucial for monitoring health metrics and tracking disease progression in real-time, allowing for more personalized and timely interventions. For example, reports from the Centers for Disease Control and Prevention (CDC) in May 2023 revealed that deaths from heart disease and cancer reached 695,547 in 2022, an increase from 605,213 in 2021. This rise in chronic diseases is expected to boost the demand for digital biomarkers.
Leading companies in the digital biomarker market are pursuing strategic partnerships to broaden their reach and enhance their offerings. A strategic partnership involves collaboration between organizations to combine resources, expertise, and efforts to achieve shared objectives. For instance, in September 2023, ProofPilot, a US-based clinical trial automation provider, entered into a strategic partnership with Eli Lilly and Company, a US-based pharmaceutical firm. This partnership integrates Lilly's innovative Magnol.AI sensor cloud platform into ProofPilot's technology suite. Magnol.AI is designed to manage high-frequency sensor data with advanced security and ease. The collaboration aims to improve digital health research by providing real-time data science capabilities and deeper insights from sensor data, supporting clinician and patient-reported outcomes to advance digital health and biomarker research.
In November 2022, CardieX Limited, an Australia-based cardiovascular technology company, acquired Blumio for an undisclosed amount. This acquisition is intended to enhance the ability of both companies to measure blood pressure non-invasively, without traditional cuffs. CardieX seeks to expand its presence in the U.S. and global markets, focusing on the vascular biohealth sector, which includes disorders related to arterial health. Blumio is a US-based technology company specializing in digital biomarkers, including wearable cardiovascular sensors.
Major companies operating in the digital biomarkers market are Pfizer Inc, Bayer AG, F Hoffmann-La Roche Ltd, Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc, Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Oura Health Oy., Evidation Health Inc, AliveCor Inc, Empatica Inc, ActiGraph LLC, VivoSense Inc, BioSensics LLC, Koneksa Health Inc, ATCOR Medical Pty Ltd, Brainomix Limited
North America was the largest region in the digital biomarkers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digital biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital biomarkers market consists of revenues earned by entities by providing services such as remote patient monitoring, health data analytics, disease prediction and management, and personalized medicine through the use of wearable devices, mobile health applications, and advanced sensors. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital biomarkers market also includes sales of data analytics platforms, biometric sensors, smart glasses and headsets, voice and speech analysis tools, fitness trackers, and digital health platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digital Biomarkers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on digital biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for digital biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The digital biomarkers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Wearable; Mobile Based Applications; Sensors; Other Types
- 2) By Clinical Practice: Diagnostic Digital Biomarkers; Monitoring Digital Biomarkers; Predictive And Prognostic Digital Biomarkers; Other Clinical Practices
- 3) By Application: Oncology; Metabolic Disease; Neurological Disease; Cardiac Disease; Other Applications
- 4) By End User: Healthcare Companies; Healthcare Providers; Payers; Other End Users
- Companies Mentioned: Pfizer Inc; Bayer AG; F Hoffmann-La Roche Ltd; Eli Lilly and Company; Koninklijke Philips NV (Philips)
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Digital Biomarkers Market Characteristics
3. Digital Biomarkers Market Trends And Strategies
4. Digital Biomarkers Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Digital Biomarkers Market Size and Growth
- 5.1. Global Digital Biomarkers Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Digital Biomarkers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Digital Biomarkers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Digital Biomarkers Market Segmentation
- 6.1. Global Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Wearable
- Mobile Based Applications
- Sensors
- Other Types
- 6.2. Global Digital Biomarkers Market, Segmentation By Clinical Practice, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Diagnostic Digital Biomarkers
- Monitoring Digital Biomarkers
- Predictive And Prognostic Digital Biomarkers
- Other Clinical Practices
- 6.3. Global Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Oncology
- Metabolic Disease
- Neurological Disease
- Cardiac Disease
- Other Applications
- 6.4. Global Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Healthcare Companies
- Healthcare Providers
- Payers
- Other End Users
7. Digital Biomarkers Market Regional And Country Analysis
- 7.1. Global Digital Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Digital Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Digital Biomarkers Market
- 8.1. Asia-Pacific Digital Biomarkers Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Digital Biomarkers Market
- 9.1. China Digital Biomarkers Market Overview
- 9.2. China Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Digital Biomarkers Market
- 10.1. India Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Digital Biomarkers Market
- 11.1. Japan Digital Biomarkers Market Overview
- 11.2. Japan Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Digital Biomarkers Market
- 12.1. Australia Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Digital Biomarkers Market
- 13.1. Indonesia Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Digital Biomarkers Market
- 14.1. South Korea Digital Biomarkers Market Overview
- 14.2. South Korea Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Digital Biomarkers Market
- 15.1. Western Europe Digital Biomarkers Market Overview
- 15.2. Western Europe Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Digital Biomarkers Market
- 16.1. UK Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Digital Biomarkers Market
- 17.1. Germany Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Digital Biomarkers Market
- 18.1. France Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Digital Biomarkers Market
- 19.1. Italy Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Digital Biomarkers Market
- 20.1. Spain Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Digital Biomarkers Market
- 21.1. Eastern Europe Digital Biomarkers Market Overview
- 21.2. Eastern Europe Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Digital Biomarkers Market
- 22.1. Russia Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Digital Biomarkers Market
- 23.1. North America Digital Biomarkers Market Overview
- 23.2. North America Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Digital Biomarkers Market
- 24.1. USA Digital Biomarkers Market Overview
- 24.2. USA Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Digital Biomarkers Market
- 25.1. Canada Digital Biomarkers Market Overview
- 25.2. Canada Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Digital Biomarkers Market
- 26.1. South America Digital Biomarkers Market Overview
- 26.2. South America Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Digital Biomarkers Market
- 27.1. Brazil Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Digital Biomarkers Market
- 28.1. Middle East Digital Biomarkers Market Overview
- 28.2. Middle East Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Digital Biomarkers Market
- 29.1. Africa Digital Biomarkers Market Overview
- 29.2. Africa Digital Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Digital Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Digital Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Digital Biomarkers Market Competitive Landscape And Company Profiles
- 30.1. Digital Biomarkers Market Competitive Landscape
- 30.2. Digital Biomarkers Market Company Profiles
- 30.2.1. Pfizer Inc
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Bayer AG
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. F Hoffmann-La Roche Ltd
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Eli Lilly and Company
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Koninklijke Philips NV (Philips)
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
31. Digital Biomarkers Market Other Major And Innovative Companies
- 31.1. GE Healthcare
- 31.2. Biogen Inc
- 31.3. Garmin Ltd.
- 31.4. Clario
- 31.5. Verily Life Sciences LLC
- 31.6. Altoida Inc.
- 31.7. BioSerenity
- 31.8. Oura Health Oy.
- 31.9. Evidation Health Inc
- 31.10. AliveCor Inc
- 31.11. Empatica Inc
- 31.12. ActiGraph LLC
- 31.13. VivoSense Inc
- 31.14. BioSensics LLC
- 31.15. Koneksa Health Inc
32. Global Digital Biomarkers Market Competitive Benchmarking
33. Global Digital Biomarkers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Digital Biomarkers Market
35. Digital Biomarkers Market Future Outlook and Potential Analysis
- 35.1 Digital Biomarkers Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Digital Biomarkers Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Digital Biomarkers Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
